Mechelen, Belgium, Leiden, the Netherlands, Pittsburgh, Pennsylvania, United States; 21 June 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG), CellPoint and AboundBio today announced that…
CELlPOINT AND HYPERTRUST CO-DEVELOP xCELLIT platform for cell therapies at the point of care Leiden (NL) / Munich (DE) – November 2021 – CellPoint and Hypertrust Patient Data Care…
CellPoint and Lonza Enter Strategic Collaboration to Deliver CAR-T
Cells to Patients at Point-of-Care
CellPoint and Lonza Enter Strategic Collaboration to Deliver CAR-T Cells to Patients at Point-of-Care Goal to rapidly develop several T-cell therapies on the Cocoon® Platform for clinical point-of-care manufacturing. Aims…